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Summary
 
The interleukin-2 receptor 
 
b
 
 chain (IL-2R
 
b
 
) is expressed on a variety of hematopoietic cell
types, including natural killer (NK) cells and nonconventional T lymphocyte subsets such as in-
testinal intraepithelial lymphocytes (IEL). However, the importance of IL-2R
 
b
 
-mediated sig-
naling in the growth and development of these cells has yet to be clearly established. We have
investigated IEL and NK cells in mice deficient for IL-2R
 
b
 
 and describe here striking defects
in the development of these cells. IL-2R
 
b
 
2
 
/
 
2
 
 mice exhibited an abnormal IEL cell population,
characterized by a dramatic reduction in T cell receptor 
 
ab
 
 CD8
 
aa
 
 and T cell receptor 
 
gd
 
lymphocytes. This selective decrease indicates that IEL can be classified into those whose
development and/or differentiation is dependent on IL-2R
 
b
 
 function and those for which
IL-2R
 
b
 
–mediated signaling is not essential. NK cell development was also found to be dis-
rupted in IL-2R
 
b
 
–deficient mice, characterized by a reduction in NK1.1
 
1
 
CD3
 
2
 
 cells in the
peripheral circulation and an absence of NK cytotoxic activity in vitro. The dependence of NK
cells and certain subclasses of IEL cells on IL-2R
 
b
 
 expression points to an essential role for sig-
naling through this receptor, presumably by IL-2 and/or IL-15, in the development of lym-
phocyte subsets of extrathymic origin.
 
T
 
he cytokine interleukin-2 (IL-2) and its receptor (IL-
2R) have long been known to play a role of prime
importance in the activation and proliferation of T lym-
phocytes (reviewed in reference 1). However, it is unclear
whether signaling via the IL-2R is required for the normal
development and differentiation of other lymphoid or my-
eloid cells. The IL-2R is expressed on T lymphocytes (1),
B cells (2), NK cells (3), neutrophils (4), and monocytes
(5). The high affinity IL-2R is composed of three subunits,
the 
 
a
 
, 
 
b
 
, and 
 
g
 
 chains, whereas the intermediate affinity
form contains only the 
 
b
 
 and 
 
g
 
 chains (6, 7). Components
of the IL-2R have been identified in other cytokine recep-
tors: the IL-2R
 
g
 
 chain (
 
g
 
c
 
, or common 
 
g
 
 chain) is com-
mon to the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors,
whereas the IL-2R
 
b
 
 chain is shared between the IL-2 and
IL-15 receptors (8).
The importance of individual IL-2R chains in signal
transduction has been clarified recently by the engineered
deletion of the gene product for each of the three known
receptor subunits. Given the diverse nature of the cytokine
receptors that contain the 
 
b
 
 and 
 
g
 
 chains, and the wide
range of cell types that express components of the IL-2R,
the disruption of multiple immunomodulatory roles might
be expected in mice deficient for any one of the three sub-
units. Mice deficient in IL-2R
 
a
 
 exhibit polyclonal T and B
cell expansion (9), which correlates with a defect in activa-
tion-induced cell death in T cells, and the development of
autoimmune disorders and inflammatory bowel disease.
Similarly, in IL-2R
 
b
 
–deficient mice, T cells are spontane-
ously activated, resulting in plasma cell accumulation and
high levels of autoantibodies (10). IL-2R
 
g
 
–deficient mice
also show a defect in mature T and B cell development, but
in contrast with the lymphoproliferation seen in IL-2R
 
a
 
–
and IL-2R
 
b
 
–deficient mice, a 10-fold reduction in abso-
lute lymphocyte numbers is observed (11). In addition, NK
cells are completely absent in IL-2R
 
g
 
–deficient mice, and
the number of intestinal intraepithelial cells (IEL)
 
1
 
 cells is
severely diminished (11). In humans, loss of the 
 
g
 
c
 
 function
leads to X-linked severe combined immunodeficiency
(SCID) (12), a disease characterized by multiple defects in
T, NK, and B cell development, as might be expected from
the impairment of several cytokine receptors (13). Thus,
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 CM, complete medium; IEL, intraepithe-
lial cells; MNC, mononulear cells; PB, peripheral blood.
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signaling via components of the IL-2R plays an essential
regulatory role in homeostasis and autoimmunity.
The importance of IL-2 and IL-15 in NK cell activation
and proliferation has been well documented (1, 8, 14). Be-
cause both cytokines signal via receptors containing the 
 
b
 
and 
 
g
 
 chains, and because IL-2R
 
g
 
–deficient mice exhibit
profound defects in IEL and NK cell development, it was
of interest to examine the role of IL-2R
 
b
 
 in these lympho-
cyte populations. We report here that expression of IL-2R
 
b
 
is crucial for the normal development of both TCR
 
gd
 
 and
TCR
 
ab
 
 CD8
 
aa
 
 IEL and for NK cells. These results sug-
gest that certain cell populations that undergo extrathymic
development and differentiation have an important devel-
opmental requirement for either IL-15 and/or IL-2.
 
Materials and Methods
 
Mice.
 
Mice deficient in IL-2R
 
b
 
 were generated as previously
described (10) and maintained under specific pathogen-free con-
ditions in our animal facility. Littermate controls were used
within experiments. Because IL-2R
 
b
 
–deficient mice develop se-
vere autoimmune disorders with age (10), all assays were per-
formed on mice 3–5 wk of age.
 
Preparation of IEL.
 
Whole small intestine was removed from
mice and the lumen flushed with MEM medium. The intestine
was incised to expose the epithelial layer, and pieces 
 
z
 
1 cm in
length were shaken in 35 ml of MEM at room temperature for 30
min to displace IEL. Cells were passed through gauze to remove
intestinal debris and centrifuged at 1,000 rpm (250 
 
g
 
) for 5 min.
Cells were resuspended in 8 ml of 44% Percoll (Sigma Chemical
Co., St. Louis, MO), overlayed onto 67.5% Percoll, and centri-
fuged at 2,100 rpm (600 
 
g
 
) for 20 min. The interface was recov-
ered, washed, and resuspended in 
 
a
 
MEM containing 10% FCS
and Hepes (CM [complete medium]). The total number of cells
isolated at this step was counted as the total IEL cell number.
 
Induction of NK Activity In Vivo.
 
Mice were injected intraperito-
neally  with 0.1 
 
m
 
g of polyinosinic:polycytidilic acid (poly[I]:
poly[C], Pharmacia, Upsala, Sweden) in 0.2 ml of PBS on day 0
and day 1. Spleens were removed on day 2, and mononuclear
cells (MNC) were isolated by density gradient centrifugation us-
ing Lympholite M (Cedarlane, Hornby, Ontario).
 
Induction of NK Activity In Vitro.
 
Spleen MNC isolated by
density gradient centrifugation were incubated with 10 ng/ml mu-
rine recombinant IL-12 (Genzyme, Cambridge, MA) for 18 h in
CM. After two washes in CM, viable MNC were counted and
cytolytic activity was assessed.
 
NK Cytotoxic Assay.
 
MNC obtained after in vivo or in vitro
induction of NK activity were added to V-bottomed plates (Micro-
well; Nunc, Raskilde, Denmark) in complete medium. The NK-
sensitive Moloney leukemia virus–induced mouse lymphoma cell
line YAC-1 was grown in CM, labeled with Na
 
2
51
 
CrO
 
4
 
 (NEN,
Boston, MA) (35 
 
m
 
Ci/10
 
6
 
 cells), and added to wells containing
effector cells. Target cell lysis was determined after a 4-h incuba-
tion by measurement of 
 
51
 
Cr release using the following formula:
percentage specific lysis 
 
5
 
 (a 
 
2
 
 b / c 
 
2
 
 b) 
 
3
 
 100%, where 
 
a
 
 
 
5
 
test release, 
 
b
 
 
 
5
 
 spontaneous release, and 
 
c
 
 
 
5
 
 release in the pres-
ence of 1% SDS. Spontaneous release was always 
 
,
 
10%.
 
mAbs.
 
mAbs used in this study were as follows: anti-mouse
CD3
 
e
 
 (FITC-conjugated, clone 145-2C11), anti-mouse Thy-1.2
(biotin-conjugated, clone 53-2.1), anti-mouse CD4 (FITC-con-
jugated, clone RM4-5), anti-mouse CD8
 
a
 
 (biotin-conjugated,
clone 53-6.7), anti-mouse CD8
 
b
 
 (PE-conjugated, clone 53-5.8),
anti-mouse TCR
 
ab
 
 (PE-conjugated, clone H57-597), anti-mouse
TCR
 
gd
 
 (FITC-conjugated, clone GL3), anti-mouse NK1.1
(PE-conjugated, clone PK136), and anti-mouse Ly-49A (PE-
conjugated, clone A1). All mAbs were from PharMingen (San
Diego, CA).
 
Flow Cytometry.
 
IEL cells, peripheral blood (PB) leukocytes,
or spleen MNC from poly(I):poly(C)–treated or untreated mice
were resuspended in 0.1 ml of PBS containing 1% BSA and 0.1%
sodium azide, and incubated with 2 
 
m
 
l of anti–CD32/CD16 (Fc
block; PharMingen) for 10 min at room temperature. Cells were
subsequently incubated on ice with mAbs for 30 min and ana-
lyzed by flow cytometry (FACScalibur
 
Ò
 
; Becton Dickinson, San
Jose, CA) using CELLQuest
 
TM
 
 software (Becton Dickinson). Vi-
able lymphocytes were gated on the basis of forward and side
scatter characteristics. A total of 10,000 gated events was analyzed
for each sample.
 
Evaluation of Cell Numbers in PB and Spleen.
 
Total numbers of
leukocytes in EDTA-anticoagulated blood and density gradient
(Lympholite M) purified spleen MNC were assessed by staining
with Turk’s stain.
 
Results and Discussion
 
IEL cells, a unique subset of lymphocytes located be-
tween the epithelial cells of the gut mucosa, have been pos-
tulated to play a key role in mucosal immunity (15). IEL
constitute the most abundant extrathymic T lymphocyte
pool and exist as a heterogeneous population (16). In the
mouse, approximately half of IEL cells resemble peripheral
T cells in that they are Thy-1
 
1
 
 and TCR
 
ab
 
1
 
. While most
of these IEL are CD8
 
ab
 
1
 
, some CD4
 
1
 
 and a few double-
positive cells are also present. In contrast, the remaining IEL
population expresses the CD8
 
aa
 
 homodimer and may be
either Thy-1
 
1
 
 or Thy-1
 
2
 
, and TCR
 
ab
 
1
 
 or TCR
 
gd
 
1
 
. Al-
though it is generally believed that TCR
 
gd
 
 IEL develop in
situ within the intestine, some controversy exists regarding
the origin of the various IEL subsets expressing TCR
 
ab
 
(17). The evidence does, however, point to an extrathymic
origin for TCR
 
ab
 
 IEL expressing CD8aa (18). This het-
erogeneity within the IEL compartment has made the exact
determination of IEL function and development difficult, and
little is known concerning the requirements for the normal
differentiation of these lymphocyte populations.
IEL have been found to express the intermediate affinity
form of the IL-2R (IL-2Rbg) (19), and examination of
IL-2Rb expression has shown that IEL with high and low
levels of IL-2Rb can be identified (20). To address the role
of IL-2Rb in IEL cell development, flow cytometric analy-
ses of IEL obtained from IL-2Rb2/2 and IL-2Rb1/2 mice
were performed. Despite an equivalent number of total IEL
cells, a distinctly different population profile was observed
in IL-2Rb2/2 mice compared with that in their IL-2R1/2
or wild-type littermates. As shown in both Fig. 1 and Table 1,
IEL from normal mice comprise heterogeneous populations
of TCRab1 and TCRgd1 cells. However, IEL from IL-
2Rb–deficient mice showed a preponderance of TCRab1
cells and a dramatic reduction in TCRgd1 cells. The normal
ratio of ab:gd cells in IEL (shown here in IL-2Rb1/2501 Suzuki et al.
mice) is z2:1, but this ratio was dramatically increased to
9:1 in IL-2Rb2/2 mice. The number of Thy-12 IEL cells
was also profoundly decreased in the absence of IL-2Rb.
In IL-2Rb1/2 mice used as controls, more than half of
both TCRab1 and TCRgd1 IEL were negative for Thy-1.
However, Thy-12 cells represented ,5% of both ab1 and
gd1 IEL in IL-2Rb–deficient mice. Immunohistological
analysis revealed cells that stained positively with anti-
TCRab mAb, but not with anti-TCRgd mAb (data not
shown), confirming the reduced number of TCRgd1 IEL
observed using FACSÒ analysis. Similar results have been
reported for other cytokine receptor mutants. In IL-7Ra
knockout mice, gd T cells (including gd IEL) failed to de-
velop, whereas ab T cells (including ab IEL) were present
in slightly reduced numbers, and NK cells were normal
(21, 22; H. Kiyono, personal communication). The deter-
mination of gd expression in spleen or lymph node cells
has proven to be problematic in IL-2Rb–deficient mice
because of the increased ab T cell and granulocyte popula-
tions occurring in these mutants. Because ab cells normally
constitute only a small proportion of overall spleen and
lymph node cells, at this time we cannot distinguish be-
tween a relative and real decrease in gd cell numbers in the
knockout mouse as a whole.
When TCRab1 IEL were analyzed for the expression
of CD8a and CD8b, a significant reduction in CD8a1b2
(CD8aa) cells was observed in IL-2Rb2/2 IEL compared
with IL-2Rb1/2 IEL (Fig. 2). Thus, IEL in IL-2Rb–defi-
cient mice can be characterized as lacking TCRgd1 and
TCRab1 CD8aa cells. Similar total numbers of IEL were
recovered after density gradient centrifugation of intestinal
cells in both IL-2Rb2/2 mice (0.8 6 0.2 3 106, n 5 4)
and IL-2Rb1/2 mice (1.1 6 0.2 3 106, n 5 5). Only
TCRab1 CD8ab1 or CD41 cells were not reduced in
IL-2Rb2/2 mice (Table 1). In fact, as previously reported
(10), the ratio of CD4:CD8 cells was elevated in IL-2Rb2/2
mice. These results clearly show that two subpopulations of
IEL exist: an IL-2Rb–dependent population, characterized
by expression of TCRab CD8aa and TCRgd, and an IL-
2Rb–independent population, characterized by TCRab
CD8ab expression. Two distinct populations of IEL cells
have been previously described (23), from which it was
proposed that those IEL undergoing thymus-dependent
development display the CD8b1 marker and those that de-
velop independently of the thymus express the CD8aa ho-
modimer. It has been postulated that this thymus-indepen-
dent population differentiates from CD32 precursors present
in the gut wall (24), and that expression of CD8aa on
these cells is induced by the immediate gut microenviron-
ment. The presence of similar numbers of CD32 cells in
the IEL populations isolated from both IL-2Rb1/2 and IL-
2Rb2/2 mice suggests that the reduction in CD8aa1 IEL
observed in IL-2Rb–deficient animals is not the result of a
lack of CD32 precursors in the gut wall, but rather due to a
lack of differentiation of these cells into CD8aa1 cells,
Figure 1. Flow cytometric analysis of Thy-1, TCRab, and TCRgd
expression on IEL from heterozygous (IL-2Rb1/2) and homozygous (IL-
2Rb2/2) IL-2Rb–deficient mice. IEL isolated from IL-2Rb1/2 or IL-
2Rb2/2 mice were stained with anti–Thy-1 mAb, and anti-TCRab or
anti-TCRgd mAb, and viable cells were analyzed by flow cytometry.
Numbers represent the percentage of total cells found in each quadrant.
Table 1. Expression of TCR, Thy-1, CD8, and CD4 in IEL of IL-2Rb–deficient Mice
CD31
CD32 (n 5 4)
TCRab1 (n 5 4) TCRab1 (n 5 3) TCRgd1 (n 5 3)
CD8aa1 CD8ab1 CD41 Thy-11 Thy-12 Thy-11 Thy-12
IL-2Rb1/2 33.0 6 5.0* 38.2 6 8.9 4.5 6 1.0 36.3 6 7.8 24.0 6 12.2 15.3 6 4.0 23.3 6 3.1 31.6 6 13.7
IL-2Rb2/2 2.8 6 2.1 56.0 6 2.8 28.3 6 1.0 91.3 6 1.5 3.0 6 1.0 7.5 6 3.5 1.7 6 3.5 34.4 6 10.2
*Numbers are mean 6 SEM percentage of CD31 cells (CD31) or CD32 lymphocytes (CD32) found in each quadrant as determined by FACSÒ
analysis.502 Intraepithelial and NK Cell Development in IL-2Rb–deficient Mice
possibly caused by a defect in gut microenvironment–IEL
interaction. Therefore, we hypothesize that the establish-
ment of a gut microenvironment that is permissive for the
development of lymphocyte subsets of extrathymic origin
is dependent on IL-15 and/or IL-2 through signaling via
the IL-2Rb chain.
The role of IL-2Rb in NK cell development and func-
tion was also investigated in this study. NK cells are lym-
phocytes capable of non-MHC-restricted cytotoxicity against
virally infected and tumor cells (25), and activated NK cells
are known to express both the high and intermediate affin-
ity IL-2 receptors (26). Because both forms of the IL-2R
contain the b chain, which is expressed at a high level in
resting NK cells (3), and anti–IL-2Rb mAb treatment leads
to long-term elimination of NK cells in vivo (27), it was
thought that the IL-2R b chain might play a role in NK
cell function and development.
NK cell–mediated cytotoxicity was evaluated using spleen
MNC as a source of NK cells and the prototypic NK target
cell line YAC-1. No cytotoxic activity was apparent in un-
stimulated spleen MNC of 3–5-wk-old wild-type or mu-
tant mice (data not shown). To study in vivo induction of
NK activity, mice were treated with the type I interferon
inducer poly(I):poly(C). While substantial NK cell–medi-
ated cytotoxic activity was induced in IL-2Rb1/2 mice, no
cytotoxic activity was apparent in spleen NK cells derived
from IL-2Rb2/2 mice (Fig. 3 A). To examine the activa-
tion of NK activity in vitro, spleen MNC from IL-2Rb1/2
and IL-2Rb2/2 mice were incubated overnight with IL-12.
IL-12 induced significant cytolytic activity in MNC of IL-
2Rb1/2 mice but was completely ineffective in inducing
detectable NK cytolytic activity in IL-2Rb2/2 MNC (Fig.
3 B). Analysis of IFN-g production (by ELISA [Intertest g;
Genzyme, Cambridge, MA]) in culture supernatants of
spleen MNC incubated with IL-12 revealed a 270-fold in-
crease in IFN-g production over unstimulated controls in
IL-2Rb1/2 cells, but only a 2-fold increase in IL-2Rb2/2
cells (data not shown). These results strongly indicate an
absence of functional NK cells in IL-2Rb–deficient mice.
To determine whether the defect in IL-2Rb2/2 NK cell
cytotoxic activity was due to a functional inactivation of
NK cells or to a block in NK cell development, NK cell
numbers were evaluated using flow cytometry (as judged
by the presence of NK1.11/CD32 cells). Absolute num-
bers of PB leukocytes and spleen MNC in IL-2Rb–defi-
cient mice were reduced compared with heterozygous
controls (Table 2). Flow cytometric analysis of lymphocytes
Figure 2. Flow cytometric analysis of CD8ab expression on TCRab1
IEL from IL-2Rb–deficient mice. IEL isolated from IL-2Rb1/2 or IL-
2Rb2/2 mice were stained with anti-CD4, anti-CD8a, and anti-CD8b
mAb. Cells gated on TCRab1 cells were analyzed for their expression of
CD8a and CD8b. Numbers represent the percentage of total cells found
in each quadrant.
Figure 3. NK cell cytolytic activity and development in IL-2Rb–defi-
cient mice. Top panels show lysis of YAC-1 target cells by (A) spleen
MNC from poly(I):(C)–treated animals or (B) spleen MNC incubated in
vitro with IL-12. IL-2Rb1/2 MNC are represented by closed symbols;
IL-2Rb2/2 MNC are represented by open symbols. Data are shown as
mean 6 SEM for (A) five IL-2Rb1/2 and five IL-2Rb/- mice and for
(B) four IL-2Rb1/2 and two IL-2Rb2/2 mice, analyzed in two separate
experiments. (C) Flow cytometric analysis of NK1.1 and CD3 expression
on NK cells in IL-2Rb–deficient mice. PB cells from IL-2Rb1/2 and IL-
2Rb2/2 mice were stained with anti-NK1.1 and anti-CD3, and 10,000
viable lymphocytes were gated. Numbers represent the percentage of
NK1.11 cells in the gated population for a representative individual from
each group.503 Suzuki et al.
from PB (Fig. 3 C; Table 2) and spleen MNC (Table 2) in
untreated mice revealed a fivefold decrease in NK1.11/
CD32 cells in IL-2Rb–deficient mice. Similar results were
obtained for PBL and spleen MNC obtained from poly(I):
poly(C)–treated animals (data not shown). IL-2Rb2/2 mice
also displayed an absence of Ly-49A1 cells both in periph-
eral blood and spleen (data not shown), confirming the ab-
sence of NK cells in these mice.
The IL-2Rb–deficient mice used in this study were gen-
erated using A129/J mice, a strain that is known to be neg-
ative for the NK1.1 surface marker of NK cells (28). It is
very unlikely that the absence of detectable NK1.1 surface
marker on IL-2Rb2/2 cells was due to the presence of
A129/J background in these mice, because they had been
backcrossed into a C57BL/6 background five times. In all
littermates examined during the course of these experiments,
IL-2Rb1/2 mice showed consistent numbers of NK1.11
cells, whereas IL-2Rb2/2 mice always displayed very low
levels of NK1.1 staining. Inadvertent deletion of the NK1.1
gene due to colocalization with the the IL-2Rb gene can
also be dismissed, since the NK gene complex (in which
the NK1.1, Ly-49, LGL-1, and NKR-P1 genes are clus-
tered) is located on distal mouse chromosome 6 (29),
whereas the IL-2Rb gene is localized on mouse chromo-
some 15 (30).
Although the b chain subunit is essential for IL-2–medi-
ated signal transduction, a defect in IL-2Rb expression does
not affect the development of classical T cells (10). Several
studies have indicated that in both mouse and human, pro-
genitor cells capable of differentiation into either T lym-
phocytes or NK cells are present in the thymus (31–33).
Those progenitors remaining within the thymus differentiate
into T cells, while those developing extrathymically be-
come NK cells (31), implying that the immediate microen-
vironment provides the required signals for a specific differ-
entiation pathway. Within the murine fetal thymus, this
bipotential progenitor cell population largely expresses not
only IL-2Rb (34, 35) but also IL-15Ra messenger RNA
(34), suggesting that these cells can respond to both IL-2
and IL-15.
It has been demonstrated that IL-2–deficient mice have
reduced but inducible NK cell–mediated cytotoxicity (36),
suggesting the existence of other compensatory IL-2R
binding molecules that may play a role in NK cell develop-
ment. IL-15 shares many of the properties of IL-2 in its po-
tentiation of NK cell cytokine production and cytotoxic
activity (14), and the IL-2Rb chain is common to the IL-2
and IL-15 receptors (8). The decrease in NK cell number
apparent in both IL-2Rb and g chain knockout mice, to-
gether with the demonstration that IL-2 is dispensable for
NK cell development (36), suggests that IL-15 may be the
more critical molecule for NK cell development. This is
supported by the observation that IL-2Rb–expressing fetal
thymic bipotential T/NK progenitor cells cultured with
IL-15 differentiated into functional NK cells capable of lys-
ing YAC-1 target cells (34). High doses of IL-2 also in-
duced differentiation into functional NK cells but did not
result in the same level of proliferation (34). It has also re-
cently been reported that IL-15 is a maturation factor for
NK cells in vitro, capable of rescuing the development of
functional NK cells from mice in which the bone marrow
microenvironment (essential for the development of fully
functional NK cells) has been disrupted (37).
Investigation of the effect of IL-15 on the differentiation
of bipotential T/NK progenitor cells in fetal thymic organ
culture has shown that low doses of IL-15, but not IL-2,
induce the expansion of TCRgd CD8aa T cells from this
progenitor population (34). This effect is blocked by the
addition of anti–IL-2Rb mAb. Similarly, treatment in utero
with anti–IL-2Rb mAb blocks the development of Vg31
dendritic epidermal cells (38), which are the developmental
progeny of Vg31 fetal thymocytes (39). That this matura-
tion may depend on IL-15–mediated (rather than IL-2–
mediated) signaling through the IL-2Rb chain is suggested
by the observation that Vg31 dendritic epidermal cells are
present in IL-2–deficient mice (40). These results, taken
together with the reduction in TCRgd CD8aa IEL ob-
served in this study, point to the importance of IL-2Rb in
the development of extrathymic TCRgd lymphocytes,
possibly as a component of the IL-15R.
Given that fetal thymic T/NK progenitors require IL-
2Rb expression for differentiation into gd and NK cells (34),
it is possible that the block in development of TCRab
CD8aa and TCRgd IEL observed in IL-2Rb–deficient
Table 2. Occurence of CD31 and NK1.11 Cells in PB and Spleen MNC of IL-2Rb–deficient Mice
PB Spleen MNC
Total leukocytes
(3 106 ml PB)
(n 5 3)
CD31
NK1.12
(Percent, n 5 13)
NK1.11
CD32
Total MNC
(3 106 ml spleen)
(n 5 3)
CD31
NK1.12
(Percent, n 5 6)
NK1.11
CD32
IL-2Rb1/2 8.6 6 0.9 *33.9 6 4.4 *2.3 6 0.3 74.3 6 5.9 ‡35.6 6 4.0 ‡2.2 6 0.4
IL-2Rb2/2 2.1 6 0.5 53.2 6 4.0 0.5 6 0.01 24.8 6 4.6 48.5 6 5.8 0.5 6 0.01
*Numbers are mean 6 SEM percentage of total leukocytes found in each quadrant as determined by FACSÒ analysis.
‡Numbers are mean 6 SEM percentage of total spleen MNC found in each quadrant as determined by FACSÒ analysis.504 Intraepithelial and NK Cell Development in IL-2Rb–deficient Mice
mice lies at an early stage of progenitor differentiation
within the thymus. However, the presence of these IEL
subsets in athymic mice (41) suggests that it is the gut mi-
croenvironment itself that determines the surface pheno-
type of the cell, and that in the absence of appropriate
IL-2Rb–mediated signaling in this location, extrathymic IEL
cannot develop. Likewise, although NK precursors are found
in the thymus, NK cell differentiation does not require the
presence of a thymus, suggesting that any developmental
block seen in IL-2Rb–deficient mice is probably associated
with a block in development or differentiation in the periph-
ery, possibly within the bone marrow microenvironment.
A subset of IEL expressing surface markers characteristic of
NK cells and capable of natural killing and antibody-depen-
dent cell-mediated cytotoxicity has recently been described
(42). Interestingly, this subset is limited exclusively to the
thymus-independent TCRab CD8aa or TCRgd popula-
tion. Therefore, it is fascinating to note that two distinct
lineages of lymphocyte capable of natural killing, the thy-
mus-independent IEL (which can now be classed as NK–T
IEL), and classical NK cells, are both critically dependent
on IL-2Rb for their normal development.
In conclusion, our observation that TCRab CD8aa
IEL, TCRgd IEL, and NK cells fail to develop in IL-2Rb–
deficient mice is supportive of a major role for IL-15 in the
development of these extrathymic lymphocyte subsets. The
a chain of the IL-15 receptor has recently been identified
and cloned (43), manipulation of which may help to clarify
the situation. The generation of a mouse with a gene-tar-
geted disruption of the IL-15 gene will no doubt elucidate
further the role of IL-15 in NK and IEL cell development.
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